Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk

Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk

Early percutaneous coronary intervention (PCI) and long-term aggressive antithrombotic treatment based on dual antiplatelet therapy (DAPT) are the most important elements in the treatment of patients with acute coronary syndrome (ACS). The most studied and recommended for ACS is the 12-month DAPT (c...

Full description

Saved in:
Bibliographic Details
Main Author: O. V. Averkov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2021-02-01
Series:Российский кардиологический журнал
Subjects:
acute coronary syndrome
percutaneous coronary intervention
dual antiplatelet therapy
bleeding risk
acetylsalicylic acid discontinuation
clopidogrel
ticagrelor
prasugrel
Online Access:https://russjcardiol.elpub.ru/jour/article/view/4305
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items